Mercado de bombas de insulina: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHE100001290
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 144
Buy Now

Se espera que el mercado de bombas de insulina crezca de 4.421,0 millones de dólares en 2019 a 8.264,0 millones de dólares en 2025; se estima que crecerá a una tasa compuesta anual del 10,5 % entre 2019 y 2025.

La bomba de insulina se utiliza para administrar insulina en el cuerpo en caso de pacientes con diabetes. La administración de insulina es la parte más importante del plan de tratamiento para pacientes con diabetes tipo 1 y tipo 2. La diabetes es uno de los principales problemas de salud cuya prevalencia está aumentando a un ritmo rápido. Por lo tanto, es necesario un diagnóstico y tratamiento tempranos de la enfermedad para evitar complicaciones adicionales, como enfermedades cardíacas.

El mercado de las bombas de insulina está segmentado por producto, tipo, aplicación y geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. Este informe ofrece información y un análisis en profundidad del mercado, enfatizando parámetros como las tendencias del mercado, la dinámica del mercado y el análisis competitivo de los actores del mercado líderes a nivel mundial.

Información estratégica

regiones lucrativas para el mercado de bombas de insulina

Perspectivas del mercado

Creciente prevalencia de diabetes y creciente avance tecnológico en El mercado de bombas de insulina impulsará el crecimiento del mercado de bombas de insulina

Según la Organización Mundial de la Salud (OMS), la diabetes es una enfermedad crónica que se produce cuando el páncreas no produce suficiente insulina o el cuerpo no utiliza la produjo insulina. La causa básica de la ceguera, la insuficiencia renal, los ataques cardíacos, los accidentes cerebrovasculares y la amputación de miembros inferiores es la diabetes. En comparación con los países de ingresos altos, ha crecido rápidamente en los países de ingresos bajos y medianos. La diabetes es un importante problema de salud pública que está alcanzando proporciones epidémicas a nivel mundial. La Organización Mundial de la Salud (OMS) estimó que la prevalencia de enfermedades crónicas no transmisibles está aumentando a un ritmo alarmante en todo el mundo. Por ejemplo, aproximadamente 422 millones de personas en todo el mundo tienen diabetes, especialmente en países de ingresos bajos y medianos, y más de 1,6 millones de muertes cada año se deben a la diabetes. En las últimas décadas, el número de casos y la prevalencia de diabetes han aumentado constantemente.

La diabetes tipo 2 es la forma más prevalente de diabetes y ha aumentado junto con los cambios culturales y sociales. En los países de altos ingresos, hasta el 91% de los adultos con esta enfermedad tienen diabetes tipo 2. Según la Federación Internacional de Diabetes (FID), uno de cada 11 adultos con diabetes en 2015 se reducirá a uno de cada 10 en 2040. A continuación se mencionan los diez principales países con diabetes en 2015. Como hay constantes lesiones causadas por la diabetes en países bajos y bajos, Tanto en los países de ingresos medios como altos, se espera que la demanda de bombas de insulina crezca durante los períodos previstos.

Además, las bombas de insulina son pequeños dispositivos computarizados para el control de la diabetes, conectados con una cánula debajo de la piel que se Se utiliza para administrar un nivel lento y continuo de insulina. El individuo puede controlar el programa dependiendo del mayor o menor requerimiento. El control óptimo de la diabetes depende de dispositivos precisos de control de la glucosa. Los crecientes avances en los dispositivos de monitoreo de glucosa han dado como resultado volúmenes de sangre requeridos más pequeños con mayor precisión. Por ejemplo, en septiembre de 2016, la FDA anunció su primer dispositivo automático de monitoreo de glucosa, el MiniMed 670G de Medtronic, un sistema híbrido de circuito cerrado que proporciona dosis basales apropiadas de insulina en personas de 14 años o más con diabetes tipo 1. Además, el dispositivo suele denominarse páncreas artificial. Además, en julio de 2018, Abbott anunció la aprobación de la FDA para el sistema de monitoreo flash de glucosa de 14 días Freestyle Libre que permite a las personas con diabetes usar el sensor durante hasta 14 días con alta precisión.

Información sobre el producto

Según el producto, el mercado de bombas de insulina se divide en bombas y accesorios. El segmento de bombas tuvo la mayor participación de mercado en 2019 y se espera que el segmento de accesorios registre la CAGR más alta durante el período de pronóstico.

Mercado de bombas de insulina, por producto: 2019 y 2025

Información sobre tipos

Según el tipo, el mercado de bombas de insulina se divide en bombas de tubo y parches zapatillas. El segmento de bombas de tubo tuvo la mayor participación del mercado en 2019, y se espera que las bombas de parche registren la CAGR más alta durante el período de pronóstico.

Application Insights

Según la aplicación, la insulina El mercado de bombas está segmentado en diabetes tipo I y diabetes tipo II. El segmento de diabetes tipo I tuvo la mayor participación del mercado en 2019, y se espera que el mismo segmento registre la CAGR más alta durante el período de pronóstico.

Desarrollos inorgánicos como fusiones y adquisiciones Las adquisiciones y la expansión son estrategias altamente adoptadas por los actores del mercado global de bombas de insulina. A continuación se enumeran algunos de los recientes desarrollos clave del mercado:

  • En mayo de 2018, Insulet Corporation celebró dos asociaciones con distribuidores capacitados para la diabetes, a saber, Nordic Infucare y Theras Group ofrecerá un servicio completo de distribución del sistema Omnipod en Italia. Estas asociaciones tienen como objetivo dirigir las operaciones en Europa para respaldar su sistema Omnipod.
  • En marzo de 2018, Ypsomed inauguró su primera filial en Canadá. La empresa prevé iniciar la producción de las primeras bombas para pacientes en octubre. Además, la compañía también lanzó la bomba de insulina mylife YpsoPump en India.
  • En enero de 2018, Valeritas anunció la disponibilidad de su dispositivo portátil de administración de insulina V-Go en Puerto Rico. Valeritas se asoció con Fusion Consulting Group de Guaynabo, Puerto Rico, para fomentar V-Go entre los médicos generales y endocrinólogos que atienden a pacientes con diabetes tipo 2.
  • En julio de 2017, Abbott y Bigfoot Biomedical firmaron un acuerdo para desarrollar y comercializar sistemas de control de la diabetes, integrando la tecnología de detección de glucosa Freestyle Libre de Abbott con las soluciones de administración de insulina de Bigfoot en los Estados Unidos.

Perfiles de la empresa

  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • KARL STORZ SE & Co. KG
  • Cell NoVo
  • SOOIL Developments Co., Ltd
  • Micro Port Scientific Corporation
  • Valeritas Inc.
  • F. Hoffmann-La Roche Ltd.
  • Psalmed AG.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is largest geographic market for insulin pumps?

North America is that the largest geographic market and it's expected to be the biggest revenue generator throughout the forecast amount.

How big is the insulin pump market?

The insulin pumps market size was calculable at US$ 4,421.0 million in 2019 and is predicted to achieve at US$ 8,264.0 Million by 2025.

What is the insulin pump market growth?

Globally, the insulin pump market is predicted to grow at a compound annual rate of growth of 10.5% throughout the forecast amount.

Who are the key players in insulin pump market?

Some key players in operation within the insulin pump market include Insulet Corporation, Medtronic, Tandem Diabetes Care, Inc, Debiotech S.A, CELLNOVO, SOOIL Developments Co., Ltd, MicroPort Scientific Corporation, Valeritas Inc., F. Hoffmann-La Roche Ltd., Ypsomed AG.

Which is base year calculated in the insulin pumps market report?

2018 is considered as base year for insulin pumps market report.

What are the key growth strategies of insulin pump market players?

Product approvals and partnerships & collaborations were determined as the most adopted strategy in insulin pumps industry, globally.

The List of Companies - Insulin Pumps Market

  1. Insulet Corporation
  2. Medtronic
  3. Tandem Diabetes Care, Inc
  4. Debiotech S.A
  5. CELLNOVO
  6. SOOIL Developments Co., Ltd
  7. MicroPort Scientific Corporation
  8. Valeritas Inc.
  9. F. Hoffmann-La Roche Ltd.
  10. Ypsomed AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports